Live Quote · NASDAQKALVHealthcare· Biotechnology

KalVista Pharmaceuticals, Inc.

$27.00▲ 0.00%(+$0.00)
MKT CAP $1.44BLAST EARNINGS Aug 13, 2026
50%
Bullish
TickerSpark Score
68/100
▌ Solid
60
Valuation
60
Profitability
50
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KALV research report →

Analyst Price Target
$28.67+6.2% vs. today

Range $27 – $32

Analyst RatingBuy
11 Buy2 Hold0 Sell

Price Chart

+106.26% · this period
$27.00$18.88$10.76Jun 12Dec 11Jun 12
52-Week Range100% of range
Low
$9.83
Current
$27.00
High
$27.00